AllianceBernstein’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-246,121
Closed -$113K 3285
2025
Q1
$113K Hold
246,121
﹤0.01% 3049
2024
Q4
$182K Sell
246,121
-26,920
-10% -$32.4K ﹤0.01% 3041
2024
Q3
$429K Hold
273,041
﹤0.01% 2741
2024
Q2
$459K Buy
273,041
+53,100
+24% +$95.3K ﹤0.01% 2717
2024
Q1
$528K Sell
219,941
-25,360
-10% -$54.5K ﹤0.01% 2567
2023
Q4
$375K Hold
245,301
﹤0.01% 2744
2023
Q3
$267K Buy
245,301
+18,190
+8% +$31.9K ﹤0.01% 2854
2023
Q2
$520K Buy
227,111
+133,700
+143% +$355K ﹤0.01% 2618
2023
Q1
$227K Buy
93,411
+3,600
+4% +$8.25K ﹤0.01% 2870
2022
Q4
$172K Buy
89,811
+4,800
+6% +$10.2K ﹤0.01% 3039
2022
Q3
$204K Buy
85,011
+28,400
+50% +$78.6K ﹤0.01% 3005
2022
Q2
$105K Buy
56,611
+6,200
+12% +$11.8K ﹤0.01% 3119
2022
Q1
$105K Buy
50,411
+300
+0.6% +$832 ﹤0.01% 3109
2021
Q4
$197K Hold
50,111
﹤0.01% 3079
2021
Q3
$241K Sell
50,111
-6,000
-11% -$24.6K ﹤0.01% 3033
2021
Q2
$258K Buy
56,111
+12,000
+27% +$57.8K ﹤0.01% 3073
2021
Q1
$259K Sell
44,111
-14,500
-25% -$100K ﹤0.01% 2966
2020
Q4
$200K Sell
58,611
-51,442
-47% -$98.1K ﹤0.01% 2996
2020
Q3
$158K Sell
110,053
-71,700
-39% -$128K ﹤0.01% 2999
2020
Q2
$363K Buy
181,753
+39,950
+28% +$78.3K ﹤0.01% 2801
2020
Q1
$277K Buy
141,803
+43,300
+44% +$129K ﹤0.01% 2658
2019
Q4
$409K Hold
98,503
﹤0.01% 2629
2019
Q3
$296K Hold
98,503
﹤0.01% 2806
2019
Q2
$620K Buy
98,503
+18,200
+23% +$109K ﹤0.01% 2511
2019
Q1
$446K Sell
80,303
-9,000
-10% -$54.7K ﹤0.01% 2561
2018
Q4
$593K Buy
89,303
+6,100
+7% +$49.4K ﹤0.01% 2407
2018
Q3
$888K Sell
83,203
-179
-0.2% -$2.05K ﹤0.01% 2388
2018
Q2
$1M Buy
83,382
+8,900
+12% +$91K ﹤0.01% 2318
2018
Q1
$638K Hold
74,482
﹤0.01% 2444
2017
Q4
$736K Sell
74,482
-107,300
-59% -$1.11M ﹤0.01% 2426
2017
Q3
$2.23M Buy
181,782
+100,000
+122% +$1.48M ﹤0.01% 1780
2017
Q2
$1.34M Sell
81,782
-107,710
-57% -$1.67M ﹤0.01% 2135
2017
Q1
$2.72M Sell
189,492
-1,080
-0.6% -$16K ﹤0.01% 1591
2016
Q4
$2.64M Sell
190,572
-14,970
-7% -$240K ﹤0.01% 1641
2016
Q3
$3.71M Buy
205,542
+62,282
+43% +$1M ﹤0.01% 1307
2016
Q2
$2.06M Buy
143,260
+79,580
+125% +$1.08M ﹤0.01% 1690
2016
Q1
$761K Sell
63,680
-671
-1% -$7.04K ﹤0.01% 2246
2015
Q4
$857K Sell
64,351
-11,750
-15% -$144K ﹤0.01% 2210
2015
Q3
$817K Sell
76,101
-4,888
-6% -$53.4K ﹤0.01% 2271
2015
Q2
$652K Buy
80,989
+9,564
+13% +$70.2K ﹤0.01% 2488
2015
Q1
$472K Buy
71,425
+6,529
+10% +$44.6K ﹤0.01% 2511
2014
Q4
$413K Sell
64,896
-4,643
-7% -$37.4K ﹤0.01% 2580
2014
Q3
$686K Sell
69,539
-1,300
-2% -$13.9K ﹤0.01% 2397
2014
Q2
$798K Sell
70,839
-74
-0.1% -$795 ﹤0.01% 2361
2014
Q1
$859K Buy
70,913
+6,686
+10% +$85.4K ﹤0.01% 2236
2013
Q4
$809K Hold
64,227
﹤0.01% 2257
2013
Q3
$1.07M Buy
64,227
+205
+0.3% +$3.44K ﹤0.01% 2094
2013
Q2
$972K Buy
+64,022
New +$973K ﹤0.01% 2094

Other funds holding LXRX